Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: Systematic review and meta-analysis

BMJ (Online)

Volumn 340, Issue 7750, 2010, Pages 795-

  Jellema, Petra ^a   Van Der Windt, Daniëlle A W M ^a,b   Bruinvels, David J ^a   Mallen, Christian D ^b   Van Weyenberg, Stijn J B ^a   Mulder, Chris J ^a   De Vet, Henrica C W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; BLOOD EXAMINATION; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONSTIPATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EVIDENCE BASED PRACTICE; FAMILY HISTORY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOCHEMISTRY; IRON DEFICIENCY ANEMIA; META ANALYSIS; OCCULT BLOOD TEST; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; SYMPTOM; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

ADULT; AGED; COLORECTAL NEOPLASMS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MIDDLE AGED; OCCULT BLOOD; PEDIGREE; QUALITY ASSURANCE, HEALTH CARE; RECTAL DISEASES; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WEIGHT LOSS;

EID: 77950683306     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1269     Document Type: Review

References (78)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
2. Davila RE, Rajan E, Baron TH, Adler DG, Egan JV, Faigel DO, et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006;63:546-57.
3. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:140-5.
4. Hamilton W, Round A, Sharp D, Peters TJ. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer 2005;93:399-405. (Pubitemid 43080012)
5. Janssen HA, Borghouts JA, Muris JW, Metsemakers JF, Koes BW, Knottnerus JA. Health status and management of chronic nonspecific abdominal complaints in general practice. Br J Gen Pract 2000;50:375-9.
6. Hamilton W, Sharp D. Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Fam Pract 2004;21:99-106. (Pubitemid 38240349)
7. Department of Health. Referral guidelines for suspected cancer. Department of Health, 2000.
8. Selvachandran SN, Hodder RJ, BallalMS, Jones P, Cade D. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002;360:278-283 (Pubitemid 34874719)
9. Rai S, Kelly MJ. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis 2007;9:195-202. (Pubitemid 46477020)
10. Thorne K, Hutchings HA, Elwyn G. The effects of the two-week rule on NHS colorectal cancer diagnostic services: a systematic literature review. BMC Health Serv Res 2006;6:43. (Pubitemid 43891688)
11. Falkson CB, Bates T. Faecal occult blood screening for patients with gastrointestinal symptoms. Br J Surg 1993;80:1326. (Pubitemid 23313175)
12. Farrands PA, O'Regan D, Taylor I. An assessment of occult blood testing to determine which patients with large bowel symptoms require urgent investigation. Br J Surg 1985;72:835-837 (Pubitemid 16193564)
13. Greenwald B. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening. Gastroenterol Nurs 2005;28:90-6.
14. Parekh M, Fendrick AM, Ladabaum U. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther 2008;27:697-712. (Pubitemid 351406306)
15. Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP. An advance notification letter increases participation in colorectal cancer screening. J Med Screen 2007;14:73-75 (Pubitemid 47067760)
16. Bachmann LM, Coray R, Estermann P, Ter Riet G. Identifying diagnostic studies inMedline: reducing thenumber needed to read. J Am Med Inform Assoc 2002;9:653-658 (Pubitemid 35231850)
17. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002;2:9.
18. Haynes RB, Wilczynski NL. Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey. BMJ 2004;328:1040.
19. Muris JW, Starmans R, Fijten GH, Crebolder HF, Schouten HJ, Knottnerus JA. Non-acute abdominal complaints in general practice: diagnostic value of signs and symptoms. Br J Gen Pract 1995;45:313-6.
20. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
21. Cochrane Collaboration. Cochrane diagnostic reviewers' handbook. John Wiley, 2005.
22. Lijmer JG, Mol BW, Heisterkamp S, BonselGJ, PrinsMH, van der Meulen JH, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282:1061-1066 (Pubitemid 29436454)
23. Rutjes AWS, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PMM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 2006;174:469-476 (Pubitemid 43294861)
24. Zamora J, Muriel A, Abrair V. Statistical methods. MetaDiSc version 1.4, 2004.
25. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982-90.
26. Gatsonis C, Paliwal P.Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 2006;187:271-281 (Pubitemid 44148267)
27. Bafandeh Y, Khoshbaten M, Eftekhar Sadat AT, Farhang S. Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study. World J Gastroenterol 2008;14:1534-1538 (Pubitemid 351460167)
28. Barwick TW, Scott SB, Ambrose NS. The two week referral for colorectal cancer: a retrospective analysis. Colorectal Dis 2004;6:85-91.
29. Bjerregaard NC, Tottrup A, Sorensen HT, Laurberg S. Diagnostic value of self-reported symptoms in Danish outpatients referred with symptoms consistent with colorectal cancer. Colorectal Dis 2007;9:443-451 (Pubitemid 46773634)
30. Bjerregaard NC, Tottrup A, Sorensen HT, Laurberg S. Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer. Scand J Gastroenterol 2007;42:228-236 (Pubitemid 46253871)
31. Castiglione G, Pacini F, Palli D. Haemoccult test and a self-administered questionnaire in the early diagnosis of colorectal cancer. Ital J Gastroenterol 1987;19:83-86 (Pubitemid 17058996)
32. Charalambopoulos A, Syrigos KN, Ho JL, Murday VA, Leicester RJ. Colonoscopy in symptomatic patients with positive family history of colorectal cancer. Anticancer Res 2000;20:1991-1994 (Pubitemid 30636170)
33. Ellis BG, Thompson MR. Factors identifying higher risk rectal bleeding in general practice. Br J Gen Pract 2005;55:949-55.
34. Fijten GH, Starmans R, Muris JW, Schouten HJ, Blijham GH, Knottnerus JA. Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice. Fam Pract 1995;12:279-86.
35. Goulston K, Davidson P. Faecal occult blood testing in patients with colonic symptoms. Med J Aust 1980;2:667-668 (Pubitemid 11114910)
36. Jeanson A, Jamart J, Maisin JM, Vanheuverzwyn R, Gohy P, Debongnie JC, et al. Assessment of the new immunological test Hemoblot for detecting occult blood in faeces. Eur J Cancer Prev 1994;3:407-412 (Pubitemid 24301640)
37. Kimmig JM, Strauch M, Hallen M. Negative Haemoccult test in malignant and premalignant lesions of the colon. Validation of the Haemoccult test with total colonoscopy. Endoscopy 1989;21:136-40.
38. Leicester RJ, Lightfoot A, Millar J, Colin-Jones DG, Hunt RH. Accuracy and value of the Hemoccult test in symptomatic patients. BMJ 1983;286:673-674 (Pubitemid 13147652)
39. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann InternMed 2007;146:244-255 (Pubitemid 351650610)
40. Mant A, Bokey EL, Chapuis PH, Killingback M, Hughes W, Koorey SG, et al. Rectal bleeding. Do other symptoms aid in diagnosis? Dis Colon Rectum 1989;32:191-6.
41. Marderstein EL, Church JM. Classic "outlet" rectal bleeding does not require full colonoscopy to exclude significant pathology. Dis Colon Rectum 2008;51:202-6.
42. Miyoshi H, Oka M, Sugi K, Saitoh O, Katsu K, Uchida K. Accuracy of detection of colorectal neoplasia using an immunochemical occult blood test in symptomatic referred patients: comparison of retrospective and prospective studies. Intern Med 2000;39:701-6.
43. Niv Y, Sperber AD. Sensitivity, specificity, and predictive value of fecal occult blood testing (Hemoccult II) for colorectal neoplasia in symptomatic patients: a prospective study with total colonoscopy. Am J Gastroenterol 1995;90:1974-7.
44. Norrelund N, Norrelund H. Colorectal cancer and polyps in patients aged 40 years and over who consult a GP with rectal bleeding. Fam Pract 1996;13:160-165 (Pubitemid 26131443)
45. Panzuto F, Chiriatti A, Bevilacqua S, Giovannetti P, Russo G, Impinna S, et al. Symptom-based approach to colorectal cancer: survey of primary care physicians in Italy. Dig Liver Dis 2003;35:869-875 (Pubitemid 41070492)
46. Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administrationmedical center. Gastrointest Endosc 2002;56:325-32.
47. Pye G, Marks CG, Martin S, Marks V, Jackson J, Hardcastle JD. An evaluation of Fecatwin/Feca EIA; a faecal occult blood test for detecting colonic neoplasia. Eur J Surg Oncol 1989;15:446-448 (Pubitemid 19263915)
48. Pye G, Jackson J, Thomas WM, Hardcastle JD. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg 1990;77:630-631 (Pubitemid 20190012)
49. Robertson R, Campbell C, Weller DP, Elton R,Mant D, Primrose J, et al. Predicting colorectal cancer risk in patients with rectal bleeding. Br J Gen Pract 2006;56:763-767 (Pubitemid 44540905)
50. Shastri YM, Loitsch S, HoepffnerN, Povse N, Hanisch E, RoschW, et al. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study. Am J Gastroenterol 2008;103:1496-1504 (Pubitemid 351813913)
51. Sieg A, ScheidaM, JohnMR,Hertel A, Schroter M, Luthgens K, et al. Validity of newimmunologicalhuman fecal hemoglobin and albumin tests in detecting colorectal neoplasms - an endoscopy-controlled study. Z Gastroenterol 1998;36:485-490 (Pubitemid 28287515)
52. SiegA, Thoms C, Luthgens K, JohnMR,Schmidt-GaykH.Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces. Int J Colorectal Dis 1999;14:267-271 (Pubitemid 30085258)
53. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobinwith a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-2159 (Pubitemid 44665648)
54. Steine S, Stordahl A, Laerum F, Laerum E. Referrals for double-contrast barium examination. Factors influencing the probability of finding polyps or cancer. Scand J Gastroenterol 1994;29:260-264 (Pubitemid 24103001)
55. Tan YM, Rosmawati M, Ranjeev P, Goh KL. Predictive factors by multivariate analysis for colorectal cancer in Malaysian patients undergoing colonoscopy. J Gastroenterol Hepatol 2002;17:281-284 (Pubitemid 34534100)
56. Tate JJ, Northway J, Royle GT, Taylor I. Evaluation of a 'DIY' test for the detection of colorectal cancer. J R Soc Med 1989;82:388-90.
57. Tate JJ, Northway J, Royle GT, Taylor I. Faecal occult blood testing in symptomatic patients: comparison of three tests. Br J Surg 1990;77:523-526 (Pubitemid 20164695)
58. Thomas WM, Hardcastle JD, Jackson J, Pye G. Chemical and immunological testing for faecal occult blood: a comparison of two tests in symptomatic patients. Br J Cancer 1992;65:618-20.
59. Thompson MR, Perera R, Senapati A, Dodds S. Predictive value of common symptomcombinations in diagnosing colorectal cancer. Br J Surg 2007;94:1260-1265 (Pubitemid 47584776)
60. Thompson MR, Flashman KG, Wooldrage K, Rogers PA, Senapati A, O'Leary DP, et al. Flexible sigmoidoscopy and whole colonic imaging in the diagnosis of cancer in patients with colorectal symptoms. Br J Surg 2008;95:1140-6.
61. Wauters H, Van Casteren V, Buntinx F. Rectal bleeding and colorectal cancer in general practice: diagnostic study. BMJ 2000;321:998-9.
62. Zarchy TM, Ershoff D. Which clinical variables predict an abnormal double-contrast barium enema result? Ann Intern Med 1991;114:137-41.
63. Bellentani S, Baldoni P, Petrella S, Tata C, Armocida C, Marchegiano P, et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group. Fam Pract 1990;7:307-12.
64. Brewster NT, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994;81:445-7.
65. Chohan DP, Goodwin K, Wilkinson S, Miller R, Hall NR. How has the 'two-week wait' rule affected the presentation of colorectal cancer? Colorectal Dis 2005;7:450-3.
66. Debnath D, Dielehner N, Gunning KA. Guidelines, compliance, and effectiveness: a 12 months' audit in an acute district general healthcare trust on the two week rule for suspected colorectal cancer. Postgrad Med J 2002;78:748-751 (Pubitemid 36051367)
67. Eccersley AJ, Wilson EM, Makris A, Novell JR. Referral guidelines for colorectal cancer - do they work? Ann R Coll Surg Engl 2003;85:107-10.
68. Flashman K, O'Leary DP, Senapati A, Thompson MR. The Department of Health's "two week standard" for bowel cancer: is it working? Gut 2004;53:387-91.
69. Mahon CC, Vaizey CJ, Taylor I, Boulos PB. Preliminary evaluation of United Kingdom national referral guidelines for lower gastrointestinal tract cancer. Colorectal Dis 2002;4:111-114 (Pubitemid 34413850)
70. Metcalf JV, Smith J, Jones R, Record CO. Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract 1996;46:161-164 (Pubitemid 26092854)
71. Tate JJ, Royle GT. Open access colonoscopy for suspected colonic neoplasia. Gut 1988;29:1322-5.
72. Hodder RJ, Ballal M, Selvachandran SN, Cade D. Pitfalls in the construction of cancer guidelines demonstrated by the analyses of colorectal referrals. Ann R Coll Surg Engl 2005;87:419-426 (Pubitemid 41645523)
73. National Institute for Health and Clinical Excellence. Referral for suspected cancer - NICE guideline. NICE, 2005.
74. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 2008;57:1545-53.
75. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann InternMed 2004;140:189-202. (Pubitemid 38155650)
76. Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B, Zurakowski D, et al. Interrater reliability in assessing quality of diagnostic accuracy studies using the QUADAS tool. A preliminary assessment. Acad Radiol 2006;13:803-10.
77. Stengel D, Bauwens K, Rademacher G, Mutze S, Ekkernkamp A. Association between compliance with methodological standards of diagnostic research and reported test accuracy: meta-analysis of focused assessment of US for trauma. Radiology 2005;236:102-111 (Pubitemid 40853301)
78. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Reitsma JB, Bossuyt PM, et al.Quality of reporting of diagnostic accuracy studies. Radiology 2005;235:347-353 (Pubitemid 40571066)